Examination of the Effectiveness of Diffusion Weighted Magnetic Resonance Imaging for Identifying Poor Prognosis in Patients With Rheumatoid Arthritis
|ClinicalTrials.gov Identifier: NCT01482507|
Recruitment Status : Unknown
Verified November 2011 by Paul Bird, Optimus Clinical Research.
Recruitment status was: Recruiting
First Posted : November 30, 2011
Last Update Posted : November 30, 2011
|Condition or disease|
Assess DWI MRI in patients with early Rheumatoid Arthritis to determine whether the MRI method will assist in differentiating poor prognosis bone oedema more effectively than traditional T2 weighted MRI.
Aim 1: To compare DWI MRI with T2 weighted MRI for the discrimination of different types of bone oedema lesions in patients with early RA.
Aim 2: To examine the association between the presence of different types of bone oedema lesions detected on DWI MRI and T2 weighted MRI and the development of subsequent joint bone erosion as detected on i) MRI and ii) standard plain radiographs.
|Study Type :||Observational|
|Estimated Enrollment :||20 participants|
|Official Title:||Examination of the Effectiveness of Diffusion Weighted Magnetic Resonance Imaging for Identifying Poor Prognosis in Patients With Rheumatoid Arthritis|
|Study Start Date :||August 2011|
|Estimated Study Completion Date :||August 2012|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01482507
|Australia, New South Wales|
|Optimus Clinical Research||Recruiting|
|Kogarah, New South Wales, Australia, 2217|
|Contact: Wendy Gellatley 61 2 95870238 firstname.lastname@example.org|
|Principal Investigator: Paul Bird, Dr|
|Principal Investigator:||Paul Bird, Dr||Optimus Clinical Research|